|
市場調査レポート
商品コード
1789246
膝軟骨修復の市場規模、シェア、成長分析、治療タイプ別、用途別、エンドユーザー別、地域別 - 産業予測、2025年～2032年Knee Cartilage Repair Market Size, Share, and Growth Analysis, By Treatment Type (Surgical Repair, Knee Cartilage Regeneration), By Application (Femoral, Tibial), By End User, By Region - Industry Forecast 2025-2032 |
||||||
|
|||||||
| 膝軟骨修復の市場規模、シェア、成長分析、治療タイプ別、用途別、エンドユーザー別、地域別 - 産業予測、2025年～2032年 |
|
出版日: 2025年08月07日
発行: SkyQuest
ページ情報: 英文 188 Pages
納期: 3～5営業日
|
- 全表示
- 概要
- 目次
膝軟骨修復の世界市場規模は、2023年に12億米ドルと評価され、2024年には12億7,000万米ドル、2032年には21億6,000万米ドルに成長すると予測され、予測期間（2025-2032年）のCAGRは6.84%で成長しています。
膝軟骨修復ソリューションの世界の需要は、膝の怪我、変形性関節症、スポーツ関連の怪我の有病率の増加から大きな影響を受けています。活動的なライフスタイル、高齢化、肥満レベルの上昇などの要因が膝関節の変性に寄与しており、医療介入が必要となっています。このような臨床ニーズの高まりは、変性関節問題と整形外科的再建治療との直接的な関連性を浮き彫りにし、膝軟骨修復の手法に対するヘルスケアプロバイダーや患者の関心の高まりにつながっています。さらに、生体材料、再生医療、低侵襲手術手技の進歩が、治療の展望を再構築しています。人工軟骨製品の承認率の上昇と整形外科研究への政府助成金が市場拡大をさらに後押しし、筋骨格系疾患の管理における確立された治療法へのシフトを示しており、市場全体の成長を促進しています。
目次
イントロダクション
- 調査の目的
- 調査範囲
- 定義
調査手法
- 情報調達
- 二次と一次データの方法
- 市場規模予測
- 市場の前提条件と制限
エグゼクティブサマリー
- 世界市場の見通し
- 供給と需要の動向分析
- セグメント別機会分析
市場力学と見通し
- 市場概要
- 市場規模
- 市場力学
- 促進要因と機会
- 抑制要因と課題
- ポーターの分析
主な市場の考察
- 重要成功要因
- 競合の程度
- 主な投資機会
- 市場エコシステム
- 市場の魅力指数（2024年）
- PESTEL分析
- マクロ経済指標
- バリューチェーン分析
- 価格分析
- ケーススタディ
- 顧客購買行動分析
膝軟骨修復市場規模：治療タイプ別& CAGR（2025-2032）
- 市場概要
- 外科的修復
- 膝軟骨再生
- 細胞ベースの軟骨表面再生
膝軟骨修復市場規模：用途別& CAGR（2025-2032）
- 市場概要
- 大腿骨
- 脛骨
- 膝蓋大腿軟骨の修復
膝軟骨修復市場規模：エンドユーザー別& CAGR（2025-2032）
- 市場概要
- 病院
- 整形外科クリニック
- 外来手術センター
膝軟骨修復市場規模：地域別& CAGR（2025-2032）
- 北米
- 米国
- カナダ
- 欧州
- ドイツ
- スペイン
- フランス
- 英国
- イタリア
- その他欧州地域
- アジア太平洋地域
- 中国
- インド
- 日本
- 韓国
- その他アジア太平洋地域
- ラテンアメリカ
- ブラジル
- その他ラテンアメリカ地域
- 中東・アフリカ
- GCC諸国
- 南アフリカ
- その他中東・アフリカ
競合情報
- 上位5社の比較
- 主要企業の市場ポジショニング（2024年）
- 主な市場企業が採用した戦略
- 最近の市場動向
- 企業の市場シェア分析（2024年）
- 主要企業の企業プロファイル
- 企業の詳細
- 製品ポートフォリオ分析
- 企業のセグメント別シェア分析
- 収益の前年比比較（2022-2024年）
主要企業プロファイル
- Smith & Nephew（United Kingdom）
- Zimmer Biomet Holdings Inc.（USA）
- Stryker Corporation（USA）
- Vericel Corporation（USA）
- DePuy Synthes（USA）
- CartiHeal Ltd.（Israel）
- Orthocell Limited（Australia）
- Mimix Biotherapeutics（Switzerland）
- TETEC AG（Germany）
- B. Braun Melsungen AG（Germany）
- Anika Therapeutics Inc.（USA）
- Tissue Regenix Group plc（United Kingdom）
- Biopolymer Solutions LLC（USA）
- Smith & Nephew Korea Ltd.（South Korea）
- ReLive Biotechnologies（India）
結論と提言
Global Knee Cartilage Repair Market size was valued at USD 1.2 Billion in 2023 poised to grow between USD 1.27 Billion in 2024 to USD 2.16 Billion by 2032, growing at a CAGR of 6.84% in the forecast period (2025-2032).
The global demand for knee cartilage repair solutions is significantly influenced by the increasing prevalence of knee injuries, osteoarthritis, and sports-related injuries. Factors such as active lifestyles, an aging population, and rising obesity levels contribute to knee joint degeneration, necessitating medical interventions. This growing clinical need highlights the direct connection between degenerative joint issues and orthopedic reconstruction treatments, leading to heightened interest from healthcare providers and patients in knee cartilage repair methods. Additionally, advancements in biomaterials, regenerative medicine, and minimally invasive surgical techniques are reshaping the treatment landscape. Increased approval rates of engineered cartilage products and government funding for orthopedic research further support market expansion, indicating a shift toward established care practices in managing musculoskeletal conditions, thus driving overall market growth.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Knee Cartilage Repair market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Knee Cartilage Repair Market Segments Analysis
The global knee cartilage repair market is segmented based on treatment type, application, end user, and region. In terms of treatment type, the market is divided into surgical repair, knee cartilage regeneration, and cell-based cartilage resurfacing. Based on application, the market is categorized into femoral, tibial, and patellofemoral cartilage repair. By end user, the market is segmented into hospitals, orthopedic clinics, and ambulatory surgical centers. Based on region, the market is segmented into North America, Europe, Asia-Pacific, Central & South America, and the Middle East & Africa.
Driver of the Global Knee Cartilage Repair Market
The global knee cartilage repair market is propelled by several significant factors, including the growing occurrence of sports-related injuries, an aging population, and a higher prevalence of osteoarthritis. Both athletes and older individuals are increasingly seeking minimally invasive and regenerative treatments for knee cartilage repair to restore mobility and shorten recovery periods. Additionally, there is a strong emphasis on healing and effective procedures for cartilage restoration, which is encouraging widespread adoption in emerging markets as well as established economies. This trend underscores the demand for innovative solutions in knee cartilage repair across various healthcare landscapes.
Restraints in the Global Knee Cartilage Repair Market
The global knee cartilage repair market faces significant challenges primarily due to the high costs associated with advanced techniques such as cell-based therapies and robotic-assisted surgeries. These financial barriers hinder widespread adoption, particularly in lower-middle-income countries where access to such innovative treatments is limited. Additionally, issues related to restricted reimbursement options and high out-of-pocket expenses further obstruct patients' ability to seek necessary care, resulting in a slower overall market expansion. These factors collectively contribute to the market's stagnation, preventing both healthcare providers and patients from fully embracing and utilizing the latest advancements in knee cartilage repair technologies.
Market Trends of the Global Knee Cartilage Repair Market
The global knee cartilage repair market is witnessing a significant shift towards innovative regenerative and cell-based therapies that prioritize the restoration of natural cartilage function. Techniques such as autologous chondrocyte implantation (ACI), stem cell therapies, and scaffold-based approaches are gaining traction, offering promising solutions to alleviate pain and enhance recovery. This trend reflects a growing demand for minimally invasive procedures that not only improve joint functionality but also postpone the necessity for total knee replacement surgeries. As advancements in technology and research continue to emerge, the market is poised for transformative growth, driven by the increasing awareness and acceptance of these advanced treatment modalities.
Table of Contents
Introduction
- Objectives of the Study
- Scope of the Report
- Definitions
Research Methodology
- Information Procurement
- Secondary & Primary Data Methods
- Market Size Estimation
- Market Assumptions & Limitations
Executive Summary
- Global Market Outlook
- Supply & Demand Trend Analysis
- Segmental Opportunity Analysis
Market Dynamics & Outlook
- Market Overview
- Market Size
- Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
- Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers
Key Market Insights
- Key Success Factors
- Degree of Competition
- Top Investment Pockets
- Market Ecosystem
- Market Attractiveness Index, 2024
- PESTEL Analysis
- Macro-Economic Indicators
- Value Chain Analysis
- Pricing Analysis
- Case Studies
- Customer Buying Behavior Analysis
Global Knee Cartilage Repair Market Size by Treatment Type & CAGR (2025-2032)
- Market Overview
- Surgical Repair
- Knee Cartilage Regeneration
- Cell-Based Cartilage Resurfacing
Global Knee Cartilage Repair Market Size by Application & CAGR (2025-2032)
- Market Overview
- Femoral
- Tibial
- Patellofemoral Cartilage Repair
Global Knee Cartilage Repair Market Size by End User & CAGR (2025-2032)
- Market Overview
- Hospitals
- Orthopedic Clinics
- Ambulatory Surgical Centers
Global Knee Cartilage Repair Market Size & CAGR (2025-2032)
- North America (Treatment Type, Application, End User)
- US
- Canada
- Europe (Treatment Type, Application, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
- Asia Pacific (Treatment Type, Application, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Latin America (Treatment Type, Application, End User)
- Brazil
- Rest of Latin America
- Middle East & Africa (Treatment Type, Application, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa
Competitive Intelligence
- Top 5 Player Comparison
- Market Positioning of Key Players, 2024
- Strategies Adopted by Key Market Players
- Recent Developments in the Market
- Company Market Share Analysis, 2024
- Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2022-2024)
Key Company Profiles
- Smith & Nephew (United Kingdom)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Zimmer Biomet Holdings Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Stryker Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Vericel Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- DePuy Synthes (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- CartiHeal Ltd. (Israel)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Orthocell Limited (Australia)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Mimix Biotherapeutics (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- TETEC AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- B. Braun Melsungen AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Anika Therapeutics Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Tissue Regenix Group plc (United Kingdom)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Biopolymer Solutions LLC (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Smith & Nephew Korea Ltd. (South Korea)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- ReLive Biotechnologies (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Conclusion & Recommendations
